General Information of Drug (ID: DM8Z5VH)

Drug Name
NN8210 Drug Info
Indication
Disease Entry ICD 11 Status REF
Rheumatoid arthritis FA20 Discontinued in Phase 1 [1]
Cross-matching ID
TTD Drug ID
DM8Z5VH

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Discontinued Drug(s)
Preclinical Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Avacopan DM5LQHB Anca-associated vasculitis 4A44.A Approved [3]
PMX-53 DMZUAJ4 Atopic dermatitis EA80 Phase 2 [4]
NN8209 DM2TDE7 Rheumatoid arthritis FA20 Discontinued in Phase 2 [2]
PMX205 DMMXR3L Central nervous system disease 8A04-8D87 Preclinical [5]
RPR121154 DM9DXHM Discovery agent N.A. Investigative [6]
W54011 DMQI7BA Discovery agent N.A. Investigative [7]
C5aR pepducins DMEK4HZ Inflammation 1A00-CA43.1 Investigative [6]
NDT9520492 DMFKX7Z Discovery agent N.A. Investigative [8]
⏷ Show the Full List of 8 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
C5a anaphylatoxin chemotactic receptor (C5AR1) TTHXFA1 C5AR1_HUMAN Modulator [2]

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800036376)
2 Complement in immune and inflammatory disorders: therapeutic interventions. J Immunol. 2013 Apr 15;190(8):3839-47.
3 Clinical pipeline report, company report or official report of ChemoCentryx.
4 Company report (Arana Therapeutics)
5 Development and validation of a LC-MS/MS assay for pharmacokinetic studies of complement C5a receptor antagonists PMX53 and PMX205 in mice. Sci Rep. 2018 May 25;8(1):8101.
6 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 32).
7 Identification of a potent and orally active non-peptide C5a receptor antagonist. J Biol Chem. 2002 Dec 20;277(51):49403-7.
8 Molecular characterization of the gerbil C5a receptor and identification of a transmembrane domain V amino acid that is crucial for small molecule ... J Biol Chem. 2005 Dec 9;280(49):40617-23.